Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Acta Neuropathologica|March 8, 2006
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's diseaseOliver Wirths, Joachim Weis, Jacek Szczygielski, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2013
Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapyOliver Wirths, Antje Hillmann, Laurent Pradier, et al.
International Journal of Molecular Sciences|February 11, 2023
A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse ModelMartina Stazi, Silvia Zampar, Hans-Wolfgang Klafki, et al.
Neuro-Degenerative Diseases|March 7, 2008
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse modelThomas A Bayer, Henning Breyhan, Kailai Duan, et al.
Brain Research|April 13, 2007
Altered cholesterol metabolism in APP695-transfected neuroblastoma cellsOliver Wirths, Karin M Thelen, Dieter Lütjohann, et al.
Neurobiology of Aging|September 12, 2006
Age-dependent axonal degeneration in an Alzheimer mouse modelOliver Wirths, Joachim Weis, Rakez Kayed, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 8, 2022
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 miceMartina Stazi, Silvia Zampar, Madeleine Nadolny, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 14, 2021
The anti-parallel dimer binding interface in STAT3 transcription factor is required for the inactivation of cytokine-mediated signal transductionPriyanka Rajeev Menon, Asmma Doudin, Anke Gregus, et al.
Pageof 12